James River’s Myron returns CEO role to Abram due to health Laura Sanicola July 31, 2019 X LinkedIn Show more sharing options Print X LinkedIn James River CEO Robert Myron is stepping down as CEO due to lingering effects from Lyme disease, according to the company. Login to continue Please enter your email address below. Login with SSO Password Login Opening your single sign-on provider... Continue or Email Sign In Link Set/Reset Password Start Free Trial Questions about your access? Refer to our FAQs for answers or appropriate contacts Request a free trial: Fuel a smarter strategy with our actionable market intelligence Gain a competitive edge and accelerate decision-making Be empowered by insights that transform confusion to clarity Uncover growth opportunities and prepare for potential threats Request a free trial Already a subscriber? Login now Back
